Core Insights - Rayonier Advanced Materials reported $417 million in revenue for Q4 2025, a year-over-year decline of 1.2% and an EPS of -$0.28 compared to -$0.10 a year ago, indicating a significant drop in profitability [1] - The revenue exceeded the Zacks Consensus Estimate of $365.5 million by 14.09%, while the EPS fell short of the consensus estimate of -$0.09 by 211.11% [1] Revenue Performance - High-Yield Pulp revenue was $28 million, surpassing the estimated $21 million [4] - Paperboard revenue reached $44 million, slightly above the estimated $42.5 million [4] - Cellulose Commodities generated $94 million, exceeding the $72.2 million estimate [4] - Cellulose Specialties revenue was $249 million, higher than the estimated $228.75 million [4] - Biomaterials revenue was $10 million, above the estimated $8.05 million [4] - Eliminations resulted in a loss of $-8 million, compared to the estimated $-7 million [4] EBITDA Analysis - EBITDA from continuing operations for Cellulose Specialties was $70 million, slightly above the $69.5 million estimate [4] - Cellulose Commodities reported an EBITDA of $-7 million, worse than the estimated $-6 million [4] - Corporate operations had an EBITDA of $-18 million, compared to the estimated $-14 million [4] - Paperboard operations generated an EBITDA of $4 million, exceeding the $3 million estimate [4] - High-Yield Pulp operations reported an EBITDA of $-5 million, in line with the estimate [4] - Biomaterials had an EBITDA of $-1 million, below the estimated $3 million [4] Stock Performance - Rayonier Advanced Materials shares returned +21% over the past month, contrasting with the Zacks S&P 500 composite's -1.3% change [3] - The stock currently holds a Zacks Rank 3 (Hold), suggesting it may perform in line with the broader market in the near term [3]

Core Insights - TD SYNNEX reported revenue of $17.38 billion for the quarter ended November 2025, marking a year-over-year increase of 9.7% and exceeding the Zacks Consensus Estimate of $16.89 billion by 2.92% [1] - The company's EPS for the same period was $3.83, up from $3.09 a year ago, although it did not meet the consensus EPS estimate of $3.68 [1] Revenue Breakdown - Revenue from the Americas was $9.51 billion, slightly below the average estimate of $9.61 billion, reflecting a year-over-year change of +2.9% [4] - Revenue from Europe reached $6.49 billion, surpassing the estimated $5.69 billion, with a year-over-year increase of +18.1% [4] - Revenue from the Asia-Pacific and Japan (APJ) region was $1.38 billion, exceeding the average estimate of $1.24 billion, representing a year-over-year growth of +24.7% [4] Stock Performance - Over the past month, shares of TD SYNNEX have returned -3.4%, contrasting with the Zacks S&P 500 composite's increase of +0.9% [3] - The stock currently holds a Zacks Rank 4 (Sell), indicating potential underperformance relative to the broader market in the near term [3]

Core Insights - Dun & Bradstreet reported revenue of $579.8 million for Q1 2025, a year-over-year increase of 2.7%, with an EPS of $0.21 compared to $0.20 a year ago, slightly missing the revenue estimate by 0.02% but exceeding EPS expectations by 5% [1][2]. Revenue Breakdown - North America revenue was $398 million, exceeding the average estimate of $397.23 million, reflecting a year-over-year increase of 3% [4]. - International revenue reached $181.80 million, slightly below the average estimate of $183.19 million, with a year-over-year change of 2.2% [4]. - Sales & Marketing revenue internationally was $59 million, surpassing the average estimate of $57.94 million, marking a 1.9% year-over-year increase [4]. - North America Sales & Marketing revenue was $181.40 million, below the average estimate of $182.89 million, with a year-over-year change of 1.6% [4]. - International Finance & Risk revenue was $122.80 million, compared to the average estimate of $125.25 million, showing a year-over-year increase of 2.3% [4]. - North America Finance & Risk revenue was $216.60 million, exceeding the average estimate of $214.33 million, with a year-over-year increase of 4.1% [4]. - Total Sales & Marketing revenue was $240.40 million, slightly below the average estimate of $241.55 million, reflecting a year-over-year change of 1.7% [4]. - Total Finance & Risk revenue was $339.40 million, exceeding the average estimate of $338.39 million, with a year-over-year increase of 3.4% [4]. Stock Performance - Dun & Bradstreet's shares returned -0.2% over the past month, outperforming the Zacks S&P 500 composite's -0.7% change, and currently holds a Zacks Rank 3 (Hold), indicating potential performance in line with the broader market [3].